Intraocular injection of bevacizumab for rubeosis capsulare in a pseudophakic eye.
J
J
Rajagopal
A G
AG
Kamath
G G
GG
Kamath
M M
MM
Rao
D000368:Aged; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D003930:Diabetic Retinopathy / Q000150:complications; D006801:Humans; D056965:Injections, Intraocular; D007903:Lens Capsule, Crystalline / Q000098:blood supply* / Q000473:pathology; D008297:Male; D009389:Neovascularization, Pathologic / Q000188:drug therapy* / Q000473:pathology; D019591:Pseudophakia / Q000150:complications*; D016896:Treatment Outcome; D014792:Visual Acuity
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab